← All Sponsors

SPONSOR

Shandong Cancer Hospital and Institute

Total Trials

5

Recruiting

5

Phases

Phase 2

Conditions studied: Rectal Malignant Neoplasms Solid Tumours Olanzapine Nausea and Vomiting Endometrial Neoplasms Neoplasm Recurrence, Local Neoplasm Metastasis Colorectal Cancer Immunotherapy Radiotherapy

NCT07026422 Phase 2

Iparomlimab/Tuvonralimab Integrating With Total Neoadjuvant Therapy for pMMR/MSS Locally Advanced Rectal Cancer (IT-TNT)

Rectal Malignant Neoplasms

Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

NCT06532539 Phase 2

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Endometrial Neoplasms

NCT06356584 Phase 2

Fruquintinib Combined With Sintilimab ± Radiotherapy for Third-line Treatment of Colorectal Cancer With Liver Metastases

Colorectal Cancer

Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma

Soft Tissue Sarcoma (STS)